`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF MASSACHUSETTS
`
`
`
`
`
`PHILIPS NORTH AMERICA LLC,
`
`
`Plaintiff,
`
`
`
`
`Civil Action No. 1:19-cv-11586-FDS
`
`
`
`
`
`
`
`
`v.
`
`FITBIT, INC.,
`
`
`
`
`
`
`Defendant.
`
`DEFENDANT FITBIT INC.’S MEMORANDUM OF LAW IN SUPPORT OF ITS
`MOTION TO COMPEL THE PRODUCTION OF
`CERTAIN OF MR. ARIE TOL’S EMAIL COMMUNICATIONS
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 2 of 25
`
`
`
`TABLE OF CONTENTS
`
`Page
`
`INTRODUCTION ...........................................................................................................................1
`
`FACTUAL BACKGROUND & DISCOVERY SOUGHT .............................................................2
`
`LEGAL STANDARDS ...................................................................................................................5
`
`ARGUMENT ...................................................................................................................................6
`
`I.
`
`A PATENT AGENT’S ADVICE THAT DOES NOT PERTAIN TO MATTERS
`BEFORE A PATENT OFFICE IS NOT PROTECTED BY ATTORNEY-
`CLIENT PRIVILEGE. .........................................................................................................6
`
`1.
`
`2.
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under U.S. Law. .......................7
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under Dutch Law. ....................9
`
`II.
`
`III.
`
`COMMUNICATIONS CONVEYING PRIMARILY BUSINESS ADVICE ARE
`NOT ATTORNEY-CLIENT PRIVILEGED OR WORK PRODUCT
`PROTECTED. ...................................................................................................................12
`
`THE REQUESTED COMMUNICATIONS ARE NOT PROTECTED UNDER
`THE WORK PRODUCT DOCTRINE. .............................................................................15
`
`CONCLUSION ..............................................................................................................................18
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`i
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 3 of 25
`
`
`
`TABLE OF AUTHORITIES
`
`CASES
`
`Page(s)
`
`Anwar v. Fairfield Greenwich Ltd.,
`982 F. Supp. 2d 260 (S.D.N.Y. 2013)....................................................................... 6, 8, 11
`
`Atchison Casting Corp. v. Marsh, Inc.,
`216 F.R.D. 225 (D. Mass. 2003) ......................................................................................... 5
`
`Bristol-Myers Squibb Co. v. Rhone-Poulenc Rorer, Inc.,
`No. 95 CIV. 8833 (RPP), 1998 WL 158958 (S.D.N.Y. Apr. 2, 1998) ............................. 12
`
`Columbia Data Prod., Inc. v. Autonomy Corp.,
`No. CIV.A. 11-12077-NMG, 2012 WL 6212898 (D. Mass. Dec. 12, 2012) ................... 16
`
`E.I. du Pont de Nemours & Co. v. MacDermid, Inc.,
`No. CIV. A. 06-3383 MLC, 2009 WL 3048421 (D.N.J. Sept. 17, 2009) .......................... 9
`
`Gucci Am., Inc. v. Guess?, Inc.,
`271 F.R.D. 58 (S.D.N.Y. 2010) .......................................................................................... 8
`
`Hickman v. Taylor,
`329 U.S. 495 (1947) ............................................................................................................ 5
`
`In re Google Inc.,
`462 F. App’x 975 (Fed. Cir. 2012) ................................................................................... 12
`
`In re Grand Jury Subpoena,
`273 F. Supp. 3d 296 (D. Mass. 2017) ................................................................................. 6
`
`In re IPCom GmbH & Co., KG,
`428 F. App'x 984 (Fed. Cir. 2011) ................................................................................ 9, 10
`
`In re Queen’s University at Kingston,
`820 F.3d 1287 (Fed. Cir. 2016)................................................................................... 6, 7, 8
`
`In re Rivastigimine Pat. Litig.,
`239 F.R.D. 351 (S.D.N.Y. 2006) ...................................................................................... 11
`
`Intell. Ventures I, LLC v. Lenovo Grp. Ltd.,
`No. 16-CV-10860-PBS, 2019 WL 9096048 (D. Mass. Dec. 6, 2019) ..... 12, 14, 15, 16, 17
`
`Massachusetts Eye and Ear Infirmary v. QLT Phototherapeutics, Inc.,
`No. 00-CV-0783 (JLT), 2001 WL 1180694 (D. Mass. Sept. 25, 2001) ........................... 16
`
`Micronics Filtration Holdings, Inc. v. Miller,
`No. 18-CV-303-JL, 2019 WL 9104172 (D.N.H. Nov. 5, 2019) ....................................... 18
`
`
`
`ii
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 4 of 25
`
`
`
`Organon, Inc. v. Mylan Pharms., Inc.,
`303 F.Supp.2d 546 (D. N.J. 2004) ...................................................................................... 9
`
`PersonalWeb Techs., LLC v. Google Inc.,
`No. 13-C-01317-EJD, 2014 WL 4088201 (N.D. Cal. Aug. 19, 2014)..…………………17
`
`
`SanDisk Corp. v. Round Rock Rsch. LLC,
`No. 11-CV-05243-RS (JSC), 2014 WL 691565 (N.D. Cal. Feb. 21, 2014) ............... 15, 18
`
`Tulip Computers International B.V. v. Dell Computer Corp.,
`2002 WL 31556497 (Nov. 15, 2002 D. Del.) ..................................................................... 9
`
`U.S. v. McLellan,
`No. 16-CR-10094-LTS, 2018 WL 9439896 (D. Mass. Jan. 19, 2018) ............................... 5
`
`U.S. v. Textron Inc. & Subsidiaries,
`577 F.3d 21 (1st Cir. 2009) ......................................................................................... 16, 18
`
`VLT Corp. v. Unitride Corp.,
`194 F.R.D. 8 (D. Mass. 2000) ......................................................................................... 5, 6
`
`OTHER AUTHORITIES
`
`Bruil v. Tital International,
`Rechtbank Zutphen [District Court of Zutphen], 1 May 1988,
`ECLI:NL:RBZUT:1988:AB8996 (Neth.) ..................................................................... 9, 10
`
`Rijkswet van 15 december 1994 [Dutch Patent Act], Articles 23, 80, and 82, available at
`https://wetten.overheid.nl/BWBR0007118/2020-04-01#Hoofdstuk6_Artikel82 ....... 10, 11
`
`The EU Single Market Regulated Professions Database: Octrooigemachtigde
`(Netherlands), available at https://ec.europa.eu/growth/tools-
`databases/regprof/index.cfm?action=regprof&id_regprof=834&tab=general ................. 11
`
`RULES
`
`Fed. R. Civ. P. 26(b)(1)................................................................................................................... 5
`
`Fed. R. Civ. P. 26(b)(3)................................................................................................................. 16
`
`Fed. R. Civ. P. 26(b)(3)(A) ........................................................................................................... 16
`
`Fed. R. Evid. 501 ............................................................................................................................ 5
`
`
`
`
`
`iii
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 5 of 25
`
`
`
`INTRODUCTION
`
`Defendant Fitbit, Inc. (“Fitbit”) moves to compel Plaintiff Philips North America LLC
`
`(“Philips”) to produce email communications Philips improperly withheld for privilege.
`
`Specifically, Fitbit seeks to compel production of emails of Mr. Arie Tol, a Dutch patent agent
`
`employed by Philips’s parent, Koninklijke Philips N.V., in its intellectual property licensing
`
`division, Philips Intellectual Property and Standards (“Philips IP&S”). Mr. Tol has first-hand
`
`knowledge regarding Philips’s licensing practices and policies, both generally and as they relate
`
`to the litigation against Fitbit—matters relevant to Fitbit’s defenses. Nonetheless, both during Mr.
`
`Tol’s deposition and in response to Fitbit’s subsequent requests for Mr. Tol’s relevant emails,
`
`Philips prevented Fitbit from obtaining this relevant discovery by improperly invoking attorney-
`
`client privilege and work product protection. Accordingly, Fitbit moves to compel certain entries
`
`on Mr. Tol’s email privilege log (attached as Exhibit A (April 16 Privilege Log)) for three reasons.
`
`First, Philips’s invocation of attorney-client privilege for communications exclusively
`
`between Dutch patent agents and other non-attorney employees who were not acting at the
`
`direction and control of a licensed attorney, and related to matters other than representation before
`
`a patent office, has no basis in U.S. or Dutch law. Patent agent privilege extends only to matters
`
`before a patent office, such as patent prosecution. As such, Philips’s claims of attorney-client
`
`privilege over communications between patent agents related to the post-issuance assertion of
`
`patents it acquired from third-parties and did not prosecute, is improper under U.S. law.
`
`Additionally, to the extent Dutch law applies—and Fitbit contends that it does not—these
`
`communications are not privileged because, like the U.S., the Netherlands does not recognize a
`
`patent agent privilege for matters other than proceedings before the Netherlands Patent Office.
`
`Second, regardless of the communicants, Philips improperly invokes attorney-client
`
`privilege for communications that appear to deal primarily with business—rather than legal—
`
`1
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 6 of 25
`
`
`
`advice, particularly communications related to Philips’s licensing business and attempts to license
`
`Fitbit or license the asserted patents. Communications dealing predominantly with business advice
`
`or negotiations do not fall within the limited purview of attorney-client privilege.
`
`Third, Philips invokes work product protection for communications as early as June
`
`2015—four years before Philips filed its complaint in this case and well before the parties even
`
`began, much less ended, amicable business discussions negotiating a potential license. Philips did
`
`not have a reasonable expectation of litigation in 2015 and has not identified any other plausible
`
`pre-filing date by which it formed a reasonable anticipation of litigation.
`
`For these three reasons, Mr. Tol’s emails are not protected from discovery by attorney-
`
`client privilege or as work product. Accordingly, Fitbit moves to compel the production of Mr.
`
`Tol’s emails reflected at Entry Nos. 3-4; 19-21; 24; 26; 28; 30-31; 35-37; 42-43; 46-48; 58-66; 70-
`
`73; 79; 82; 144; 155-156; 162-163; 208-209; 244-248; 260-270; 299-301; 349-350; 364; 382-383;
`
`392; 394-395; 408; 412-431; 433; 437-438; 440-441; 443; 450-451; 458-460; and 463-464 in
`
`Philips’s April 16 log.1 (Ex. A).
`
`FACTUAL BACKGROUND & DISCOVERY SOUGHT
`
`Philips acquired U.S. Patent Nos. 6,013,007 (“the ’007 patent”); 7,088,233 (“the ’233
`
`patent”); and 8,277,377 (“the ’377 patent”) (collectively, the “Patents-in-Suit”) from third-parties
`
`after they were prosecuted and issued. On October 10, 2016, Philips sent a letter to Fitbit stating
`
`that “Philips is willing to discuss with Fitbit the terms and conditions of a non-exclusive,
`
`worldwide license” for a variety of patents, including the currently-asserted patents in this case.
`
`
`1 Philips’s May 28 and June 11 supplemental logs, (Exs. L & M), are not comprehensive; they
`relate to only a subset of the entries identified on the April 16 log. As such, Fitbit identifies the
`entry numbers enumerated on the April 16 log, the most recent complete log served by Philips.
`Because Philips’s privilege logs themselves have been marked confidential in their entirety, entries
`not subject to this motion have been redacted.
`
`
`
`2
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 7 of 25
`
`
`
`(Ex. B (Licensing Letters).) Philips sent similar correspondence to Fitbit on March 23 and April
`
`13, 2017. (Id.) The parties subsequently discussed the possibility of what Philips called “business
`
`discussions” related to a potential license throughout 2017 and 2018. (See Ex. C (2017 email
`
`exchange); Ex. D (2018-2019 email exchange).) Despite these ongoing negotiations, Philips filed
`
`the complaint in this matter on July 22, 2019.2
`
`Philips licenses its intellectual property through its IP&S division, which is authorized to
`
`license patents owned by Philips’s parent, Koninklijke Philips N.V. (See Ex. E (Tol Dep. Tr.) at
`
`12:18-18:7; Ex. B.) Mr. Arie Tol is a registered Dutch patent agent (or “octrooigemachtigden”)
`
`employed by Philips IP&S at its headquarters in Eindhoven, The Netherlands; Mr. Tol’s primary
`
`responsibility is licensing Philips’s patents, not patent prosecution. (See Ex. E at 11:2-12:17.)
`
`While Philips will likely refer to Mr. Tol as a “Dutch Patent Attorney,” Mr. Tol is not a bar-
`
`admitted Dutch attorney-at-law (or “advocaat”). This title instead relates to his status as a patent
`
`agent admitted to practice before the Netherlands Patent Office.
`
`Pursuant to his duties at Philips IP&S, Mr. Tol has first-hand knowledge of Philips’s
`
`licensing practices and policies, including Philips’s attempts to license the Patents-in-Suit to Fitbit
`
`and others. Indeed, Mr. Tol was Philips’s primary representative in licensing discussions with
`
`Fitbit. Nonetheless, Philips omitted Mr. Tol from its original Initial Disclosures and did not amend
`
`its disclosures to include Mr. Tol until January 22, 2021—more than a week after Mr. Tol was
`
`deposed. (See Ex. F (Philips Initial Disclosures); Ex. G (Philips Amended Initial Disclosures).)
`
`Despite Philips’s omission, Fitbit sought discovery into Mr. Tol’s knowledge and
`
`communications regarding Philips’s licensing practices and related topics during Mr. Tol’s
`
`
`2 While Philips filed an infringement action against Fitbit in Germany in December of 2017, it
`continued to pursue commercial discussions with Fitbit in the U.S. through the service of the
`complaint in mid-2019.
`
`
`
`3
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 8 of 25
`
`
`
`January 13, 2021 deposition. However, Mr. Tol refused to testify as to those matters based on an
`
`incorrect instruction from Philips’s counsel that such information is protected by attorney-client
`
`privilege. (See, e.g. Ex. E at 59:3-62:1; Ex. H (January 2021 Letter to Philips).) As Fitbit was
`
`unable to question Mr. Tol about those topics during his original deposition and Philips refused to
`
`make Mr. Tol available for additional questioning (see Ex. I (February 2021 email from Philips)),
`
`Fitbit subsequently requested that Philips search Mr. Tol’s electronically stored information,
`
`including emails, for relevant communications.3
`
`While Philips agreed to search Mr. Tol’s emails and ultimately produced a subset of the
`
`email search hits on March 23, 2021—the last day of fact discovery—it also produced a privilege
`
`log describing more than five-hundred of Mr. Tol’s emails that hit on the search terms, but were
`
`withheld for privilege. Philips’s March 23 log continued to improperly assert attorney-client
`
`privilege and work product protection as to communications that either: (1) occurred between
`
`individuals to whom attorney-client privilege does not apply; (2) deal with subject matter—namely
`
`business advice related to Philips’s commercial licensing practices—that is not privileged; or (3)
`
`occurred well-before Philips could have plausibly formed a reasonable anticipation of litigation
`
`such that work product protection could apply. (See Ex. J (March 23 Privilege Log).)
`
`The parties met and conferred regarding Philips’s March 23 log, after which Philips agreed
`
`to reevaluate the log in light of case law raised by Fitbit, namely that business advice is typically
`
`not privileged. Philips subsequently produced an amended log on April 16, 2021 (see Ex. A),
`
`removing some entries that reflect non-privileged business advice, but retaining many others with
`
`modified descriptions—which previously suggested the communications deal with non-privileged
`
`
`3 Pursuant to the email discovery provisions in the Stipulated Discovery plan, Fitbit requested these
`communications via search terms. (See D.I. 59.)
`4
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 9 of 25
`
`
`
`discussions related to licensing—to instead indicate that the entries reflect legal advice.
`
`The parties subsequently met and conferred about Philips’s amended log, and Philips
`
`agreed to further assess the April 16 amended log and provide additional information
`
`substantiating its bases for asserting privilege. Fitbit also requested that Philips name the employer
`
`of each individual on Philips’s log and specify whether or not each individual is a bar-admitted
`
`attorney-at-law (or “advocaat”). Philips provided that information via email. (See Ex. K.)
`
`On May 28, 2021 and again on June 11, after multiple meet and confers, Philips amended
`
`its April 16 log twice more, each time removing additional entries that it agrees were improperly
`
`withheld as privileged and amending—or, in some instances, completely revising—the
`
`descriptions of others. (See Ex. L (May 28 Log); Ex. M (June 11 Log).) Nonetheless, Philips’s
`
`operative logs retain numerous entries reflecting improperly withheld communications. The
`
`parties have met and conferred regarding these issues on multiple occasions, but are at an impasse.
`
`LEGAL STANDARDS
`
`A party may obtain discovery of “any non-privileged matter that is relevant to any party’s
`
`claim or defense and proportional to the needs of the case….” Fed. R. Civ. P. 26(b)(1). “The
`
`broad scope of the discovery rules reflects a policy that ‘[m]utual knowledge of all the relevant
`
`facts gathered by both parties is essential to proper litigation.’” Atchison Casting Corp. v. Marsh,
`
`Inc., 216 F.R.D. 225, 227 (D. Mass. 2003) (quoting Hickman v. Taylor, 329 U.S. 495, 507 (1947)).
`
`“The common law—as interpreted by the United States courts in the light of reason and
`
`experience—governs a claim of privilege.” Fed. R. Evid. 501. Pursuant to this Rule, U.S. courts
`
`may apply the privilege law of foreign jurisdictions “when those jurisdictions have a strong interest
`
`in the relationship at issue.” VLT Corp. v. Unitride Corp., 194 F.R.D. 8, 14-15 (D. Mass. 2000).
`
`To determine whether U.S. or foreign privilege law applies to a given communication, courts in
`
`the First Circuit apply the “touching base” test. See, e.g., id. at 15-16; U.S. v. McLellan, No. 16-
`5
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 10 of 25
`
`
`
`CR-10094-LTS, 2018 WL 9439896, at *1-2 (D. Mass. Jan. 19, 2018).
`
`“If a communication has nothing to do with the United States
`or…[has] only an incidental connection to this country, the privilege
`issue will be determined by the law of the foreign nation. If,
`however,
`the communication has more
`than an
`incidental
`connection to the United States, the courts will undertake a more
`traditional analysis and defer to the privilege of the nation having
`the most direct and compelling interest in the communication….”
`
`VLT Corp., 194 F.R.D. at 16. “Communications concerning legal proceedings in the United States
`
`or advice regarding United States law are typically governed by United States privilege law, while
`
`communications relating to foreign legal proceedings or foreign law are generally governed by
`
`foreign privilege law.” Anwar v. Fairfield Greenwich Ltd., 982 F. Supp. 2d 260, 263 (S.D.N.Y.
`
`2013) (applying the touching base test to communications with foreign patent agents).
`
`The party asserting attorney-client privilege or work product protection bears the burden
`
`to prove that the withheld documents are, in fact, covered by the claimed privilege or protection.
`
`See, e.g., In re Queen’s Univ. at Kingston, 820 F.3d 1287, 1291 (Fed. Cir. 2016) (attorney-client
`
`privilege); In re Grand Jury Subpoena, 273 F. Supp. 3d 296, 304 (D. Mass. 2017) (work-product).
`
`ARGUMENT
`
`I.
`
`A PATENT AGENT’S ADVICE THAT DOES NOT PERTAIN TO MATTERS
`BEFORE A PATENT OFFICE IS NOT PROTECTED BY ATTORNEY-CLIENT
`PRIVILEGE.
`
`Philips withheld emails between Mr. Tol and other patent agents or non-attorney Philips
`
`employees that do not relate to proceedings before a patent office, and Philips has not indicated
`
`that these communications were made at the direction of or relayed the advice of any attorney.
`
`Such communications are not entitled to patent agent privilege or attorney-client privilege. The
`
`emails corresponding to the following entries on Philips’s April 16 log involve communications
`
`exclusively between Philips’s in-house patent agents and other non-attorney employees: 3-4; 26;
`
`
`
`6
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 11 of 25
`
`
`
`28; 42; 46-48; 58-59; 65-66; 82; 155-156; 208-209; 349-350.4 These emails primarily relate to
`
`the present U.S. litigation and Philips’s pre-suit investigation. As such, they touch base with the
`
`U.S. and are governed by U.S. privilege law.
`
`Because communications related to patent validity or infringement pertain to the Federal
`
`Circuit’s exclusive jurisdiction, the application of privilege to such communications is governed
`
`by Federal Circuit law. See, e.g., In re Queen’s, 820 F.3d at 1301. The scope of privilege for
`
`patent agents not acting under the direction or control of a licensed attorney is limited. Importantly,
`
`“[c]ommunications that are not reasonably necessary and incident to the prosecution of patents
`
`before the Patent Office fall outside the scope of the patent-agent privilege.” Id. at 1301. “For
`
`instance, communications with a patent agent who is offering an opinion on the validity of another
`
`party’s patent in contemplation of litigation or for the sale or purchase of a patent, or on
`
`infringement,” are not per se privileged. Id. at 1301-02.
`
`Because the U.S. does not recognize a privilege for patent agent communications unrelated
`
`to proceedings before a patent office, these emails are not privileged and should be produced.
`
`Moreover, even if these emails touch base with the Netherlands and Dutch privilege law applies,
`
`they still are not privileged because, like the U.S., the Netherlands does not recognize a privilege
`
`for patent agent communications unrelated to patent office proceedings.5
`
`1.
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under U.S. Law.
`
`Philips withheld numerous communications between Mr. Tol and other Dutch patent
`
`agents or non-attorney employees on the basis of attorney-client privilege. As described in
`
`
`4 Philips’s claims of work product protection for these communications is also incorrect, as
`addressed below.
`5 The scope of patent-agent privilege in other jurisdictions is beyond the scope of this brief, and
`Fitbit takes no position on such issues.
`
`
`
`7
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 12 of 25
`
`
`
`Philips’s April 16 and supplemental logs, these communications predominantly relate to Philips’s
`
`purported “pre-suit investigation” of Fitbit,6 or Philips’s “ongoing and threatened litigation with
`
`Fitbit” in the U.S.7 (See, e.g., Ex. A at Entry Nos. 3-4; 246-248.) Thus, these communications
`
`relate to Fitbit’s alleged infringement of U.S. patents arising from conduct within the U.S. and the
`
`present U.S. patent infringement action. Such communications clearly have more than an
`
`“incidental relationship” to the U.S. Indeed, the U.S. has a direct and compelling interest in
`
`ensuring that its intellectual property laws are enforced according to and consistent with the
`
`procedures and policies embedded in federal law. As such, these communications touch base with
`
`the U.S. and are governed by U.S. privilege law. See, e.g., Anwar, 982 F. Supp. 2d at 263; Gucci
`
`Am., Inc. v. Guess?, Inc., 271 F.R.D. 58, 65 (S.D.N.Y. 2010).
`
`Mr. Tol and the other participants on the above-identified communications are either Dutch
`
`patent agents or non-attorney employees—not licensed attorneys. Under U.S. privilege law,
`
`“[c]ommunications that are not reasonably necessary and incident to the prosecution of patents
`
`before the Patent Office fall outside the scope of the patent-agent privilege.” In re Queen’s, 820
`
`F.3d at 1301. Thus, for example, “communications with a patent agent who is offering an opinion
`
`on…the sale or purchase of a patent, or on infringement,” are not privileged. Id. at 1301-02.
`
`Consequently, Dutch patent agent communications relating to licensing, pre-suit investigations of
`
`infringement, or “ongoing or threatened” litigation do not fall within the limited scope of the
`
`patent-agent privilege. Nor is there any indication that privilege might apply because these
`
`
`6 As explained below, Fitbit believes that many of these communications in fact relate to Philips’s
`efforts and negotiations to license its patents to Fitbit in the U.S., rather than investigation or
`preparation for litigation.
`7 Entry Nos. 42-43, 46-47, and 155-156 purportedly relate to amendments to a patent purchase
`agreement between Philips and Roger Quy, a U.S. citizen and the named inventor and previous
`owner of the ’377 Patent. Because these communications relate to a transaction with a party in the
`U.S. for rights in a U.S. patent, these communications also touch base with the U.S.
`8
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 13 of 25
`
`
`
`individuals were acting under the direction and supervision of licensed attorneys in the course of
`
`these communications. See, e.g., E.I. du Pont de Nemours & Co. v. MacDermid, Inc., No. CIV.
`
`A. 06-3383 MLC, 2009 WL 3048421, at *4 (D.N.J. Sept. 17, 2009) (finding that communications
`
`made to patentee’s in-house patent agent were not privileged because the agent “was not acting
`
`under the authority and control” of a licensed attorney). Indeed, in the course of providing its June
`
`11 supplemental privilege log, Philips specifically noted that other entries contained the advice of
`
`attorneys not directly party to the communication (see e.g., Ex. M at Entry Nos. 6-8), but made no
`
`such representation as to these entries, further suggesting that licensed attorneys were not involved
`
`in any way. Accordingly, Philips cannot withhold these communications on the basis of attorney-
`
`client privilege.
`
`2.
`
`Patent Agent Communications Concerning Purported Pre-Suit
`Investigations And Litigation Are Not Privileged Under Dutch Law.
`
`While Fitbit believes that U.S. law applies to the aforementioned patent agent
`
`communications under the touching base test, applying Dutch law does not change the outcome.8
`
`Like the U.S., the Netherlands does not recognize a privilege for patent agent
`
`communications concerning topics other than proceedings before a patent office. See Bruil v. Tital
`
`International, Rechtbank Zutphen
`
`[District Court of Zutphen], 1 May 1988,
`
`ECLI:NL:RBZUT:1988:AB8996 (Neth.)9; Tulip Computers International B.V. v. Dell Computer
`
`Corp., 2002 WL 31556497, at *1 (Nov. 15, 2002 D. Del.); Organon, Inc. v. Mylan Pharms., Inc.,
`
`303 F.Supp.2d 546, 547 (D. N.J. 2004) (interpreting Bruil to hold “that a [Dutch] patent agent may
`
`not assert the privilege of non-disclosure for acts beyond the scope of his specific duties in
`
`
`8 Because the choice of law issue is not dispositive, the court may render a decision based purely
`on U.S. law. See, e.g., In re IPCom GmbH & Co., KG, 428 F. App'x 984, 986 (Fed. Cir. 2011).
`9 A translated copy of a summary of this decision is attached as Ex. N. Despite diligent efforts,
`Fitbit was unable to locate a copy of the full decision in this matter.
`9
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 14 of 25
`
`
`
`rendering assistance with respect to patent applications.”). As explained in Bruil v. Tital
`
`International, to Fitbit’s knowledge the only Dutch case law opining directly on the matter, the
`
`scope of a Dutch patent agent’s privilege is limited to those specific activities for which s/he is
`
`licensed—namely, “rendering assistance with the patent application.” (Ex. N at 1.) And while
`
`subsequent amendments to the Dutch Patent Act (“DPA”) have acknowledged that Dutch patent
`
`agents may more generally assist with acts and proceedings before the Netherlands Patent Office
`
`and limited proceedings before the District Court of the Hague, the scope of a patent agent’s
`
`licensure remains limited to those specific activities and, in particular, does not extend to the
`
`general context of litigation, which requires admission to the Netherlands bar as an advocaat. See
`
`Rijkswet van 15 December 1994
`
`[Dutch Patent Act], Article 82, available at
`
`https://wetten.overheid.nl/BWBR0007118/2020-04-01#Hoofdstuk6_Artikel82.10
`
`During the parties’ meet and confers, Philips put forth a number of arguments purportedly
`
`showing that, under Dutch law, a Dutch patent agent’s communications regarding matters not
`
`before a patent office are nonetheless privileged. None are convincing, particularly since U.S. law
`
`applies to the relevant communications under the touching base test.
`
`First, Philips argued that such communications are de facto protected from discovery
`
`because “Dutch courts do not provide for automatic discovery” and consequently “Dutch law
`
`would protect these materials from discovery, regardless of whether a specific privilege applies.”
`
`(See Ex. O (May 28 email from Philips).) Philips “cannot use [Dutch] discovery laws to shield
`
`itself from producing documents that can be used to attack the validity or enforceability of its
`
`patents” in U.S. litigation. In re IPCom, 428 F. App’x at 986.
`
`Second, Philips argued that the Dutch Code of Civil Procedure (“DCCP”) provides only
`
`
`10 All relevant sections of the DPA referenced herein are also attached as Exhibit S.
`10
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 15 of 25
`
`
`
`“for a narrow and limited means to seek a court order demanding the production of documents”
`
`and that “internal confidential communications of Philips’s Dutch Patent Attorneys would never
`
`qualify for such relief.” (Ex. O.) But this argument has already been rejected by U.S. courts. See,
`
`e.g., Anwar, 982 F. Supp. 2d at 266-68 (finding that “Dutch law allows wide-ranging document
`
`disclosure” and requiring the production of communications of defendant’s in-house lawyer).
`
`Third, Philips argues that the DCCP and DPA require patent agents to maintain the
`
`confidentiality of information disclosed to them in the course of their profession as patent agents.11
`
`(See Ex. O.) First, such provisions “create at most a professional secrecy obligation for patent
`
`agents, not an absolute evidentiary privilege comparable to U.S. attorney-client privilege.” In re
`
`Rivastigimine Pat. Litig., 239 F.R.D. 351, 357 (S.D.N.Y. 2006) (finding the comparable Swiss
`
`statutes did not protect communications of Swiss patent agents from discovery). Second, such
`
`provisions do not apply to the communications at issue because the subject matter of those
`
`communications—U.S. litigation—does not fall within the professional capacity of a Dutch patent
`
`agent as such. See The EU Single Market Regulated Professions Database: Octrooigemachtigde
`
`(Netherlands) (explaining that patent agents “take[] care of the procedures for the acquisition and
`
`maintenance of protection at the Netherland Patent Office” and that “[t]he exclusive service for
`
`patent attorneys is limited to represent the client for the NL patent office with the exception of
`
`services that are of administrative nature such as filing translations and the payment of annual
`
`fees.”),
`
`available
`
`at
`
`https://ec.europa.eu/growth/toolsdatabases/regprof/index.cfm?action=regprof&id_regprof=834&
`
`
`11 For example, Article 23b of the DPA provides that “a patent attorney or a person working under
`his responsibility is obliged to observe secrecy with regard to all information of which he becomes
`aware by virtue of his activities as such.” Dutch Patent Act, Article 23b, available at
`https://wetten.overheid.nl/BWBR0007118/2010-10-10#Hoofdstuk2_Paragraaf1a_Artikel23a.
`11
`
`
`
`
`
`Case 1:19-cv-11586-FDS Document 199 Filed 06/18/21 Page 16 of 25
`
`
`
`tab=general.
`
`In sum, to the extent Philips’s Dutch patent agents engage in activities beyond
`
`representation before a patent office, they do so outside the scope of their capacity as a patent agent
`
`and any attendant privilege under Dutch law. While it may be true that in practice, Philips’s patent
`
`agents’ responsibilities are broader than representation before the patent office, tha